These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9949971)

  • 1. Weight loss is often a problem in late PD.
    Jacques C; Davies R; Friedman JH
    J Neurosci Nurs; 1998 Dec; 30(6):342. PubMed ID: 9949971
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiparkinsonian drugs and "sleep attacks".
    Moller H
    CMAJ; 2001 Apr; 164(7):1038-9, 1042-3. PubMed ID: 11314438
    [No Abstract]   [Full Text] [Related]  

  • 3. Digest of evidence ... pramipexole and Parkinson's disease.
    Earl-Slater A; Walley T
    Clin Perform Qual Health Care; 2000; 8(4):240-4. PubMed ID: 11189086
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
    Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic cluster headache responsive to pramipexole.
    Palmieri A
    Cephalalgia; 2006 Jun; 26(6):761-2. PubMed ID: 16686920
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dopamine agonist is effective in Parkinson disease not only against tremor. Depression is also improved].
    MMW Fortschr Med; 2002 May; Suppl 2():88. PubMed ID: 12070869
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal learning in Parkinson's disease depends on medication status and outcome valence.
    Cools R; Altamirano L; D'Esposito M
    Neuropsychologia; 2006; 44(10):1663-73. PubMed ID: 16730032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pramipexole, ropinirole, and mania in Parkinson's disease.
    Singh A; Althoff R; Martineau RJ; Jacobson J
    Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
    Marras C; Lang A; Krahn M; Tomlinson G; Naglie G;
    Mov Disord; 2004 Jan; 19(1):22-8. PubMed ID: 14743356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of color vision during long-term treatment with pramipexole.
    Müller T; Przuntek H; Kuhlmann A
    J Neurol; 2003 Jan; 250(1):101-2. PubMed ID: 12528002
    [No Abstract]   [Full Text] [Related]  

  • 11. Gambling and Parkinson disease.
    Lu C; Bharmal A; Suchowersky O
    Arch Neurol; 2006 Feb; 63(2):298. PubMed ID: 16476827
    [No Abstract]   [Full Text] [Related]  

  • 12. Does L-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease?
    Pålhagen S; Lorefält B; Carlsson M; Ganowiak W; Toss G; Unosson M; Granérus AK
    Acta Neurol Scand; 2005 Jan; 111(1):12-20. PubMed ID: 15595933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
    Mizuno Y; Yanagisawa N; Kuno S; Yamamoto M; Hasegawa K; Origasa H; Kowa H;
    Mov Disord; 2003 Oct; 18(10):1149-56. PubMed ID: 14534919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Between Scylla and Charybdis: drug-induced psychosis in patients with Parkinson disease].
    Kuiper MA; Zwaan WA; Wolters EC
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1353-7. PubMed ID: 8035892
    [No Abstract]   [Full Text] [Related]  

  • 15. Pramipexole and somnolence.
    Shuster J
    Nursing; 2000 Aug; 30(8):81. PubMed ID: 10983129
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of sudden onset of sleep in Parkinson's disease.
    Körner Y; Meindorfner C; Möller JC; Stiasny-Kolster K; Haja D; Cassel W; Oertel WH; Krüger HP
    Mov Disord; 2004 Nov; 19(11):1298-305. PubMed ID: 15389999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pramipexole on the onset of levodopa-related dyskinesias.
    Constantinescu R; Romer M; McDermott MP; Kamp C; Kieburtz K;
    Mov Disord; 2007 Jul; 22(9):1317-9. PubMed ID: 17534955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep episodes in Parkinson's disease: a wake-up call.
    Frucht SJ; Greene PE; Fahn S
    Mov Disord; 2000 Jul; 15(4):601-3. PubMed ID: 10928569
    [No Abstract]   [Full Text] [Related]  

  • 19. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathologic gambling as an adverse effect of the treatment for Parkinson's disease].
    Miranda M; Slachevsky A; Bustamante L; Pérez C
    Rev Med Chil; 2010 Apr; 138(4):521-2. PubMed ID: 20668805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.